PR Newswire | Nov 24, 2020 04:00PM EST

reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Evolus, Inc.

11/24 15:00 CST

EVOLUS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Evolus, Inc.LEAD PLAINTIFF DEADLINE IS DECEMBER 15, 2020 NEW YORK, Nov. 24, 2020

NEW YORK, Nov. 24, 2020 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Evolus, Inc. ("Evolus" or the "Company") (NASDAQ: EOLS) on behalf of all persons or entities that purchased or otherwise acquired Evolus stock between February 1, 2019 and July 6, 2020, both dates inclusive (the "Class Period").

All investors who purchased shares ofEvolus, Inc. and incurred losses are urgedto contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action or join the case on our website, www.whafh.com.

If you have incurred losses in the shares of Evolus, Inc., youmay,no later than December 15, 2020,request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in the shares of Evolus, Inc.

CLICK HERE TO JOIN CASE

On July 6, 2020, the Initial Final Determination was issued by the United States International Trade Commission ("ITC") in a case brought by Allergan and Medytox against Evolus, asserting that Evolus stole certain trade secrets to develop Jeuveau(tm). The ITC Judge determined that the Company misappropriated the botulinum toxin strain as well as the manufacturing processes that led to its development and manufacture. As a result, the ITC Judge recommended a ten-year long ban on the Company's ability to import Jeuveau(tm) into the United States and a ten-year-long cease and desist order preventing Evolus from selling Jeuveau(tm) in the United States.

On this news, the Company's share price declined materially, falling 37% over the course of two trading days, to close at $3.35 on July 8, 2020

Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com.

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP Kevin Cooper, Esq.Gregory Stone, Director of Case and Financial Analysis Email: gstone@whafh.com, kcooper@whafh.com or classmember@whafh.comTel: (800) 575-0735 or (212) 545-4774

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View original content to download multimedia: http://www.prnewswire.com/news-releases/evolus-inc-class-action-alert-wolf-haldenstein-adler-freeman--herz-llp-reminds-investors-that-a-securities-class-action-lawsuit-has-been-filed-in-the-united-states-district-court-for-the-southern-district-of-new-york-on-behalf-301180007.html

SOURCE Wolf Haldenstein Adler Freeman & Herz LLP